See also this year's filing and all EDGAR filings for this company.
PDF Report 0001442836_2021_Mersana_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001442836, Mersana Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 258,580,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,730,000 |
| 3 | remainder_Assets | 13,089,000 |
| 4 | LiabilitiesCurrent | 30,003,000 |
| 5 | LiabilitiesNoncurrent | 15,309,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 26,261,085 |
| 9 | ResearchAndDevelopmentExpense | 70,179,968 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 42,079,408 |
| 12 | remainder_NetIncome | 498,383 |
| 13 | remainder_ComprehensiveNetIncome | -2,357 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 273,399,000 |
| 1 | Liabilities | 45,312,000 |
| 2 | Expenses | 96,441,053 |
| 3 | Revenues | 42,079,408 |
| 4 | StockholdersEquity | 228,087,000 |
| 5 | NetIncome | -53,863,262 |
| 6 | ComprehensiveNetIncome | -53,864,440 |
| 7 | BaseVar | 228,866,100 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.78 |
| 9 | EconomicCapitalRatio | 3.54 |
Edgar->Model Mapping
Feature Distribution
Change over Time
